Minimizing imposed expiratory resistance of mechanical ventilator by optimizing exhalation valve control

Information

  • Patent Grant
  • 9144658
  • Patent Number
    9,144,658
  • Date Filed
    Monday, April 30, 2012
    12 years ago
  • Date Issued
    Tuesday, September 29, 2015
    8 years ago
Abstract
This disclosure describes systems and methods for controlling an exhalation valve based on pressure and/or flow measurements during exhalation. The disclosure describes novel exhalation valve controls for ventilating a patient.
Description
INTRODUCTION

Medical ventilator systems have long been used to provide supplemental oxygen support to patients. These ventilators typically comprise a source of pressurized air and oxygen, which is fluidly connected to the patient through a conduit or tubing. The amount of pressure in the gas mixture delivered to the patient may be controlled during ventilation including during inspiration and exhalation.


Patients on a ventilator system are more comfortable when the delivered volume of inspired gas is allowed to be exhaled against the least resistance possible. Generally, resistance is due to the pneumatics of the ventilator, including the tubing, patient interface, exhalation valve, etc., and the respiratory physiology of the patient, including the lungs, bronchiole tubing, etc. Some exhalation modes are designed to open the exhalation valve to the greatest extent possible in order to provide the least amount of resistance to patient exhalation. However, these modes may enable exhalation gases to escape so quickly that the pressure in the patient's lungs falls below a prescribed positive end-expiratory pressure (PEEP). This may endanger the patient by, at best, preventing optimal oxygen exchange, and at worst, allowing alveoli in the lungs to collapse. Alternatively, other exhalation modes are designed to slowly reduce the pressure in the patient tubing to prevent undershoot of the prescribed PEEP, but at the expense of patient comfort.


SUMMARY

This disclosure describes systems and methods for controlling pressure and/or flow during exhalation in order to quickly reduce pressure in the circuit without undershooting PEEP. The disclosure describes novel exhalation modes for ventilating a patient.


In part, this disclosure describes a method for controlling exhalation during ventilation of a patient on a ventilator. The method includes:


a) determining a control command for an exhalation valve, wherein the control command targets a pressure at the exhalation valve between a minimum pressure and a steady-state pressure for a period of time;


b) controlling the exhalation valve based on the control command during one or more exhalation cycles;


c) monitoring an end exhalation pressure and a flow undershoot during the one or more exhalation cycles;


d) comparing the end exhalation pressure to a predetermined pressure range;


e) comparing the flow undershoot to a predetermined flow threshold; and


f) based on the comparing, updating the control command in order to maintain a positive-end expiratory pressure (PEEP) at the end of the one or more exhalation cycles.


Yet another aspect of this disclosure describes a ventilator system including:


a) means for determining a control command for an exhalation valve, wherein the control command targets a pressure at the exhalation valve between a minimum pressure and a steady-state pressure for a period of time;


b) means for controlling the exhalation valve based on the control command during one or more exhalation cycles;


c) means for monitoring an end exhalation pressure and a flow undershoot during the one or more exhalation cycles;


d) means for comparing the end exhalation pressure to a predetermined pressure range;


e) means for comparing the flow undershoot to a predetermined flow threshold; and


f) based on the comparing, means for updating the control command in order to maintain a positive-end expiratory pressure (PEEP) at the end of the one or more exhalation cycles.


The disclosure further describes a computer-readable medium having computer-executable instructions for performing a method controlling exhalation during ventilation of a patient on a ventilator. The method includes:


a) determining a control command for an exhalation valve, wherein the control command targets a pressure at the exhalation valve between a minimum pressure and a steady-state pressure for a period of time;


b) repeatedly controlling the exhalation valve based on the control command during one or more exhalation cycles;


c) repeatedly monitoring an end exhalation pressure and a flow undershoot during the one or more exhalation cycles;


d) repeatedly comparing the end exhalation pressure to a predetermined pressure range;


e) repeatedly comparing the flow undershoot to a predetermined flow threshold; and


f) based on the comparing, repeatedly updating the control command in order to maintain a positive-end expiratory pressure (PEEP) at the end of the one or more exhalation cycles.


These and various other features as well as advantages which characterize the systems and methods described herein will be apparent from a reading of the following detailed description and a review of the associated drawings. Additional features are set forth in the description which follows, and in part will be apparent from the description, or may be learned by practice of the technology. The benefits and features of the technology will be realized and attained by the structure particularly pointed out in the written description and claims hereof as well as the appended drawings.


It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory and are intended to provide further explanation of the disclosure as claimed.





BRIEF DESCRIPTION OF THE FIGURES

The following drawing figures, which form a part of this application, are illustrative of embodiments, systems and methods described below and are not meant to limit the scope of the invention in any manner, which scope shall be based on the claims appended hereto.



FIG. 1 is a schematic block diagram illustrating one embodiment of a ventilator.



FIGS. 2A and 2B are graphs illustrating two embodiments of pressure and flow trajectories during exhalation of an exemplary patient on a ventilator.



FIG. 3 illustrates an embodiment of a method for controlling exhalation during ventilation of a patient on a ventilator;



FIG. 4 illustrates one embodiment of operation 306 of FIG. 3.



FIG. 5 illustrates one embodiment of operations 406 and 408 of FIG. 4.



FIG. 6 illustrates one embodiment of operations 410 and 412 of FIG. 4.



FIG. 7 is a graph illustrating one embodiment of circuit pressure and exhalation valve control command during each breath of the initialization operation 304 of FIG. 3.





DETAILED DESCRIPTION

Although the techniques introduced above and discussed in detail below may be implemented for a variety of medical devices, the present disclosure will discuss the implementation of these techniques in the context of a medical ventilator for use in providing ventilation support to a human patient. The reader will understand that the technology described in the context of a medical ventilator for human patients could be adapted for use with other systems, such as ventilators for non-human patients and general gas transport systems.


Medical ventilators are used to provide a breathing gas to a patient who may otherwise be unable to breathe sufficiently. In modern medical facilities, pressurized air and oxygen sources are often available from wall outlets. Accordingly, ventilators may provide pressure regulating valves (or regulators) for controlling pressure in the ventilator circuit during inhalation and exhalation. For example, the ventilator may be connected to centralized sources of pressurized air and pressurized oxygen and may comprise one or more pressure regulating inspiratory valves for regulating the flow or pressure of gases delivered to the patient during inhalation. The regulating inspiratory valves function to regulate flow so that respiratory gases having a desired concentration of oxygen are supplied to the patient at a desired pressure and rate. Additionally, the ventilator may comprise an exhalation valve, which controls the pressure and rate of gases released from the patient circuit during exhalation (i.e., exhaled gases) and/or inhalation (i.e., in the case of inspiratory pressure overshoot). Ventilators capable of operating independently of external sources of pressurized air are also available.


Patients may require respiratory support for a number of reasons. For example, patients may have healthy lungs, but may be ventilated during an invasive surgery. Alternatively, patients may require respiratory support because they are unable to breathe independently because their lungs are diseased or injured. Diseases affecting the lungs include Chronic Obstructive Pulmonary Disease (COPD), emphysema, pneumonia, lung cancer, pulmonary embolism, etc. In many cases, oxygen exchange may be increased if a minimum, positive pressure of gases (i.e., PEEP) is maintained in the alveoli. Moreover, in some cases, if a minimum amount of pressure is not maintained in the lungs, the alveoli may collapse and become adherent at the end of exhalation and then be torn open during the next inhalation—causing additional damage to the lungs. Accordingly, PEEP is often prescribed for ventilated patients.


As discussed above, ventilated patients are more comfortable when the delivered volume of inspired gases is exhaled against the least resistance possible. Indeed, much of the resistance to exhalation is due to the exhalation valve itself. However, allowing exhaled gases to escape in an unregulated manner may allow the pressure in the patient's lungs to fall below PEEP. As such, embodiments described herein provide for regulating the exhalation valve to quickly release pressure in the patient circuit, which minimizes resistance and increases patient comfort, while at the same time regulating the exhalation valve to prevent PEEP undershoot in the lungs.



FIG. 1 is a diagram illustrating an embodiment of an exemplary ventilator 100 connected to a human patient 150. Ventilator 100 includes a pneumatic system 102 (also referred to as a pressure generating system 102) for circulating breathing gases to and from patient 150 via the ventilation tubing system 130, which couples the patient 150 to the pneumatic system 102 via an invasive (e.g., endotracheal tube, as shown) or a non-invasive (e.g., nasal mask) patient interface 180.


Ventilation tubing system 130 (or patient circuit 130) may be a two-limb (shown) or a one-limb circuit for carrying gases to and from the patient 150. In a two-limb embodiment, a fitting, typically referred to as a “wye-fitting” 170, may be provided to couple a patient interface 180 (as shown, an endotracheal tube) to an inspiratory limb 132 and an expiratory limb 134 of the ventilation tubing system 130.


Pneumatic system 102 may be configured in a variety of ways. In the present example, pneumatic system 102 includes an expiratory module 108 coupled with the expiratory limb 134 and an inspiratory module 104 coupled with the inspiratory limb 132. Compressor 106 or other sources) of pressurized gases (e.g., air, oxygen, and/or helium) is coupled with inspiratory module 104 and the expiratory module 108 to provide a gas source for ventilatory support via inspiratory limb 132.


The pneumatic system 102 may include a variety of other components, including mixing modules, valves, sensors, tubing, accumulators, filters, etc. Controller 110 is operatively coupled with pneumatic system 102, signal measurement and acquisition systems, and an operator interface 120 that may enable an operator to interact with the ventilator 100 (e.g., change ventilator settings, select operational modes, view monitored parameters, etc.). Controller 110 may include memory 112, one or more processors 116, storage 114, and/or other components of the type commonly found in command and control computing devices. In the depicted example, operator interface 120 includes a display 122 that may be touch-sensitive and/or voice-activated, enabling the display 122 to serve both as an input and output device.


The memory 112 includes non-transitory, computer-readable storage media that stores software that is executed by the processor 116 and which controls the operation of the ventilator 100. In an embodiment, the memory 112 includes one or more solid-state storage devices such as flash memory chips. In an alternative embodiment, the memory 112 may be mass storage connected to the processor 116 through a mass storage controller (not shown) and a communications bus (not shown). Although the description of computer-readable media contained herein refers to a solid-state storage, it should be appreciated by those skilled in the art that computer-readable storage media can be any available media that can be accessed by the processor 116. That is, computer-readable storage media includes non-transitory, volatile and non-volatile, removable and non-removable media implemented in any method or technology for storage of information such as computer-readable instructions, data structures, program modules or other data. For example, computer-readable storage media includes RAM, ROM, EPROM, EEPROM, flash memory or other solid state memory technology, CD-ROM, DVD, or other optical storage, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other medium which can be used to store the desired information and which can be accessed by the computer.


The inspiratory module 104 determines the pressure of gases delivered during inspiration. The expiratory module 108 determines the pressure of gases in the patient circuit during exhalation. In one embodiment, the inspiratory module 104 and the expiratory module 108 determine the pressures during ventilation by controlling valves and/or gas flow within the ventilator 100. According to embodiments, pressure in the patient circuit reaches a maximum toward the end of inhalation (e.g., peak inspiratory pressure). Thereafter, as the patient begins to exhale, pressure is released from patient's lungs via the patient circuit based on a pressure gradient between the patient's lungs and ambient atmospheric pressure (about 0 cm H2O). According to embodiments, pressure in the patient circuit may be regulated during exhalation by controlling the extent to which the exhalation valve opens or closes (i.e., regulating the rate at which gases are released from the system). For example, when the exhalation valve is opened to a greater extent, gases are allowed to escape more quickly from the patient circuit (reducing pressure in the patient circuit more quickly). Alternatively, when the exhalation valve is opened to a lesser extent, gases are allowed to escape less quickly from the patient circuit (reducing pressure in the patient circuit more slowly).


According to embodiments, pressure in the patient circuit may be regulated during the entire period of exhalation, such as the amount of pressure released per second or millisecond of the exhalation time period. According to further embodiments, the inspiratory module 104 and the expiratory module 108 may determine the pressures during ventilation by sending instructions (also known as a control commands) to the controller 110, which regulates the valves to control gas flow into or out of the patient circuit during ventilation.


According to embodiments, the exhalation valve in modern mechanical ventilators acts as a variable flow resistor during exhalation. As such, it can cause an increase in the imposed expiratory resistance placed upon the patient which leads to an increased work-of-breathing. As used herein, the term “work-of-breathing” refers to the effort exerted by the patient to inspire and/or exhale gases. Resistance may be reduced by opening the valve to a greater extent and allowing gases to be released from the patient circuit more quickly. However, as specified above, the exhalation valve is regulated such that pressure in the patient's lungs does not fall below PEEP. Moreover, the exhalation valve is regulated to prevent undesired oscillatory behavior of the pressure and flow in the patient circuit. For example, oscillatory behavior can result from nonlinearities of the pneumatic characteristics of the exhalation valve, high bandwidth of the control command, limitations of the sample rate of the control system, and latency of the real-time control command, etc.


In an effort to decrease resistance while preventing PEEP undershoot, systems and methods described herein utilize an expiratory module 108 that functions based on a time-variant expiratory pressure target during exhalation to ensure a faster exhalation time without allowing an undershoot in the lung pressure. Furthermore, systems and methods described herein utilize art exhalation valve control command based on results from an initialization to attenuate the oscillations in pressure and flow at the exhalation valve based on an individual patient. Moreover, systems and methods herein utilize feedback control to fine-tune the expiratory pressure target in order to achieve and maintain PEEP.



FIGS. 2A and 2B are graphs illustrating two embodiments of pressure and flow trajectories during exhalation of an exemplary patient on a ventilator. More specifically, FIG. 2A is a graph 200 showing an exhalation valve pressure trajectory 202, a lung pressure trajectory 204, a lung flow trajectory 206, and a desired PEEP level 208 at the lung. FIG. 2B is a graph 210 showing an exhalation valve pressure trajectory 212, a lung pressure trajectory 214, and a lung flow trajectory 216. In general, graphs 200 and 210 are exemplary embodiments of pressure and flow trajectories based on differing time constants generated by the ventilator.


The graph 200 shows the ideal pressure and flow trajectories of the patient during exhalation. As shown, the desired PEEP level 208, 5 cmH2O, is reached at the end of exhalation by the lung pressure trajectory 204, without undershoot. Furthermore, though the exhalation valve pressure trajectory 202 undershoots the desired PEEP level 208 for approximately 1.5 seconds, the exhalation valve pressure trajectory 202 eventually stabilizes at the desired PEEP level 208, in the ideal amount of time to ensure that the lung pressure trajectory 204 does not undershoot PEEP. This ideal time is known as the tau time constant, and can be altered by the ventilator to adjust the lung pressure trajectory 204.


As shown in the graph 200, the pressure trajectories are more aggressive than modern mechanical ventilators. The exhalation valve pressure trajectory 202 initially drops to a reference value of 0 cmH2O, instead of the desired PEEP level 208. By changing the reference pressure, the exhalation time is decreased substantially, as shown by the lung pressure trajectory 204. However, because the exhalation time decreases, the time constant is especially important to monitor so that there is no undershoot of the lung pressure.



FIG. 2B provides graph 210, which illustrates one embodiment in which lung pressure undershoot may occur. As shown, in the graph 210, the time it takes for the exhalation valve pressure trajectory 212 to achieve the desired PEEP level is almost 2 seconds, instead of 1.5 seconds in the graph 200. This minor yet substantial change in the time constant can negatively affect the lung pressure trajectory 214, as shown in the graph 210. As illustrated, the lung pressure trajectory 214 experiences PEEP undershoot.


Furthermore, the increased time constant also affects the lung flow trajectory 216. In comparison to the lung flow trajectory 206 of the graph 200, the lung flow trajectory 216 achieves stabilization in a far greater amount of time. In some patients, this can translate into greater discomfort and negative oscillations. Thus, the graphs 200 and 210 demonstrate that a more aggressive pressure trajectory can be utilized during exhalation, as long as, certain variables, such as the time constant, are calibrated on a patient-by-patient basis.


In general, this disclosure describes embodiments that utilize the concept of a more aggressive initial pressure reference as part of a modified exhalation valve control command provided to the controller 110. The exhalation valve control command determines the opening of the exhalation valve, and thus, the amount of time needed for gas to be exhaled by the patient 150. More specifically, the modified exhalation valve control command is developed through an initialization period in which several command values may be trained utilizing the more aggressive pressure trajectory discussed above. Next, ventilation is delivered based on the values trained in the initialization period with frequent monitoring of pressure and flow to ensure stability.



FIG. 3 illustrates an embodiment of a method 300 for controlling exhalation during ventilation of a patient on a ventilator, such as the ventilator 100. The method 300 includes an initiation operation 302, an initialization operation 304, a ventilation delivery operation 306, an end condition determination operation 308, and an end operation 310.


As illustrated, method 300 begins at the start of ventilation (operation 302). The ventilator 100 then moves to the initialization operation 304 in which the ventilator 100 determines initial values that are later used for a control command that is sent to the controller 110. Specifically, during the initialization operation 304, the ventilator 100 receives a predetermined clinician-inputted desired PEEP-level. Based on this information, and the individual characteristics of the patient, the ventilator 100 determines the appropriate reference pressure, as discussed above in relation to FIGS. 2A and 2B. Based on this reference pressure, the controller 110 determines a pressure for a first number of cycles of breaths. For example, in some embodiments, the ventilator 100 may monitor the lung pressure trajectory and the exhalation valve pressure trajectory of the patient 150 during the first two cycles of breath. In other embodiments, the ventilator 100 may monitor these pressures of the patient 150 during more or less cycles of breath.


During the initialization operation 304, the controller 110 determines minimum and steady-state values (u0 and uss) (706 and 710, respectively, in FIG. 7) of the exhalation valve control command during these first cycles of breath and ensures that these values remain stable during each breath of the initialization operation 304. Through this initialization period, values may be trained differently for different patients, based on specifics of each patient. Various factors may alter the values based on the patient's body. For example, such factors may include, but are not limited to, the patient resistance and compliance due to patient physiology, such as the size of the lungs, the health status of the patient (i.e., any diseases or medical conditions), health risks associated with the patient, gender, age, or any other physiological factors that may affect resistance and/or compliance of the lungs.


The minimum (u0) and steady-state (uss) values 706,710 are illustrated in FIG. 7. A graph 700 depicts an exhalation valve control command 702 and a circuit pressure 704 during a breath. As shown, the minimum value (u0) 706 is the minimum value of the exhalation valve control command, which occurs at the initiation 708 of the exhalation phase. The steady state value (uss) 710 is a steady-state value of the exhalation valve control command during the steady-state period 712 of the exhalation phase (i.e., during the later portion of exhalation when the circuit pressure 704 has stabilized). During the initialization operation 304, the controller 110 determines these values over a predetermined number of initial exhalation cycles.


Upon determining u0 and uss, the ventilator 100 begins the ventilation delivery operation 306, where ventilation continues over one or more breaths and, during exhalation, the exhalation valve is controlled based on the control command. Specifically, the initial values, u0 and uss, determined from the initialization operation 304 are utilized to develop a modified exhalation valve control command. To determine the exhalation valve control command (u(tk)) during ventilation delivery operation 306, the initial values (uss, u0) are inputted into the following equations:

u(tk)=(uss−u0)*(1−exp(−tk/tau))+u0; where
tau=sum*(sample period)/(uss−u0); and where
sum=sum+uss−u0.

In the above equations, the tau represents the time constant and the sample period is the amount of breath cycles in the initialization operation 304. Upon inputting the known variables after the initialization operation 304, the ventilation delivery operation 306 begins and during each exhalation phase, the exhalation valve is controlled based on the control command signal (u), which remains a function of time (tk).


The ventilator 100 continues to control the exhalation valve based on the above exhalation control command until the end condition detection operation 308 detects an end condition. Examples of end conditions include a change in the mode setting, a change in clinician-inputted values, a disconnection of the ventilator, an alarm setting, an operation failure, an occurrence of apnea, or the like. If an end condition is not detected by operation 308, the ventilator 100 continues to ventilate the patient and control the exhalation valve during exhalation based on the control command. However, if an end condition is detected by operation 308, the ventilator 100 discontinues ventilation and terminates at the end operation 310.



FIG. 4 illustrates an embodiment of what occurs during the ventilation delivery operation 306 of the method 300. Specifically, FIG. 4 illustrates a method 400 for controlling the opening of the exhalation valve, and thereby the exhalation gasses released, during the exhalation phase.


The method 400 begins upon the detection of exhalation at an operation 402. Upon detecting exhalation, the method 400 delivers ventilation based on the control command signal u(tk) that was determined during the initialization operation 304. During each exhalation, the method 400 controls the exhalation valve and monitors the stability and consistency of the pressure and flow from one exhalation to the next. This ensures a smoother exhalation control command, and thus, fewer undesired oscillations experienced by the patient.


For example, upon detecting exhalation at operation 402, the ventilator controls the exhalation valve based on the current values at operation 404. More specifically, the ventilator 100 determines whether the measured end exhalation pressure (“EEP”) of the exhalation valve is within some predetermined range (operation 406). The predetermined range may be any range determined by the controller 110 or a clinician prior to exhalation based on factors varying based on each patient, such as, the size of the lungs, the health status of the patient, health risks associated with the patient, or any other individual factors that may affect ventilation. For example, the range may be determined based on a maximum allowable threshold difference between the EEP and the desired PEEP level. The EEP is determined by pressure sensors positioned in the pneumatic system 102, for example, at the exhalation valve.


Upon comparing the EEP measurements with the predetermined allowable range, the operation 406 determines whether the EEP is at an acceptable level. If the ventilator 100 determines that the EEP falls outside of the predetermined range, the method 400 initiates a PEEP correction operation 408. In general, the PEEP correction operation 408 monitors the pressure trajectory of the exhalation valve, and adjusts the trajectory so that the EEP of the exhalation valve falls within the predetermined range. The determination operation 406 and the PEEP correction operation 408 are discussed in greater detail below in reference to FIG. 5.


Additionally, the method 400 monitors the expiratory flow undershoot at an operation 410. At operation 410, the ventilator 100 determines whether the expiratory flow of the exhalation valve is under a predetermined threshold. It is important to note that the predetermined threshold of the expiratory flow undershoot is different than the predetermined range discussed above in relation to the EEP threshold. Also, the predetermined threshold of the expiratory flow undershoot may be any threshold determined by the controller 110 or a clinician prior to exhalation based on the factors discussed above. The expiratory flow is measured by sensors positioned in the pneumatic system 102, for example, at the exhalation valve. From this measurement, the controller 110 can determine the expiratory flow undershoot and then compare this measurement to the predetermined threshold.


If the ventilator 100 determines that the expiratory flow undershoot at the exhalation valve is above the predetermined threshold, the method 400 initiates a tau value correction operation 412. In general, at operation 412, the tau value utilized in the exhalation valve control command (u(tk)), is adjusted so that the expiratory flow undershoot is regulated under the predetermined threshold. Thus, the operation 412 adjusts the control command that is sent to the controller 110 which alters the positioning of the exhalation valve. The determination operation 410 and the tau value correction operation 412 is discussed in greater detail in relation to FIG. 6.


If, on the other hand, the ventilator 100 determines that the expiratory flow undershoot at the exhalation valve is under the predetermined threshold, the ventilator 100 continues to control the exhalation valve based on any updated values that may have been corrected during either the PEEP correction operation 408 or the tau value correction operation 412. If no values were adjusted, the operation 414 continues to control the exhalation valve based on values from the previous breath cycle until the end of the current exhalation. Upon beginning the subsequent exhalation, the method 400 begins again at operation 402.



FIG. 5 illustrates an embodiment of what occurs during the EEP determination operation 406 and the PEEP correction operation 408 of the method 400. Specifically, FIG. 5 illustrates a method 500 for determining the EEP of the exhalation valve and updating the pressure trajectory of the exhalation valve during ventilation if necessary.


As illustrated, the method 500 begins at the start of exhalation (operation 502). The method 500 then enters an average EEP calculation operation 504. During the operation 504, the ventilator 100 calculates an average EEP based on a predetermined number of previous exhalations. For example, the calculation could be based on the past ten exhalations. In other embodiments, the predetermined number of previous exhalations could be any number deemed appropriate by a clinician or determined by the controller 110. For example, the calculation could be programmed so that initial calculation of the average EEP are based on fewer cycles of exhalation whereas later calculations of the average EEP are based on greater cycles of exhalation. The exact EEP measurements of each exhalation are measured by pressure sensors positioned on or around the exhalation valve and stored in the memory 112. At operation 504, the ventilator 100 utilizes the measurements stored in the memory 112 for a previous number of prior exhalations to determine the average EEP.


Upon determining the average EEP for the current exhalation, the method 500 determines how close the average EEP is to the clinician-inputted PEEP level at operation 506. This reference value is discussed in greater detail above in relation to the initialization operation 304 in FIG. 3. Specifically, the operation 506 calculates the difference between the clinician-inputted PEEP level and the average EEP. Next, the operation 506 determines whether the difference falls within a predetermined range based on the clinician-inputted PEEP level. For example, in some embodiments, the predetermined range may be between 0 and 0.25 cmH2O. However, in other embodiments this range may vary based on the factors relating to the unique needs of individual patients, as discussed above.


If the operation 506 determines that the average EEP does not fall within the predetermined threshold, the method 500 moves to a peep correction operation 508. The peep correction operation 508 utilizes the following equation:

peepCorrection=peepCorrection+0.75*(PEEP−AverageEEP).

In the equation, PEEP is the clinician-inputted PEEP level, AverageEEP is the average EEP that is determined in the operation 504, and peepCorrection is the correction, if any, that was made in the previous exhalation cycle. If no correction was made in the previous exhalation cycle, peepCorrection=0.


After determining the peepCorrection value in operation 508, the method 500 moves to operation 510 in which the peepCorrection value is utilized to alter the control command signal that is sent to the controller 110 to alter the position of the exhalation valve. Specifically, the operation 508 utilizes the following equation to alter the control command (u(tk)):

u(kk)=u(tk)PREVIOUS+peepCorrection.

In this equation, as illustrated, u(tk)PREVIOUS is the control command that was utilized in the previous exhalation cycle.


Upon altering the control command (u(tk)), the method 500 terminates at an end operation 512. The method 500 is called again to monitor the average EEP of the exhalation valve at the start of the next exhalation cycle.



FIG. 6 illustrates an embodiment of what occurs during the expiratory flow undershoot determination operation 410 and the tau value correction operation 412 of the method 400. Specifically, FIG. 6 illustrates a method 600 for determining the expiratory flow undershoot and updating the tau value, and thus, the control command of the exhalation valve during ventilation if necessary.


As illustrated, the method 600 begins at an initial point 602. The method 600 then enters an expiratory flow undershoot operation 604. At operation 604, the ventilator 100 measures the expiratory flow of the exhalation valve through flow sensors positioned on or around the exhalation valve. Based on these measurements, the ventilator 100 determines whether there is an undershoot in the expiratory flow and, if so, the amount of undershoot present.


Upon determining the undershoot, the method 600 moves to an operation 606 where the ventilator 100 compares the measured undershoot from operation 604 to a predetermined threshold. For example, in some embodiments, the predetermined threshold may be 0.2 L/min. However, in other embodiments, the predetermined threshold may vary based on the factors that differ for individual patients, discussed above. If it is determined that the measured undershoot falls below the predetermined threshold, the method 600 will terminate at an end operation 612. However, if the measured undershoot falls above the predetermined undershoot flow threshold, the method 600 moves to a tau correction operation 608.


In an embodiment, the tau correction operation 608 updates the time constant, tau, by a fixed amount, in this case a reduction of 10%, utilizing the following equation:

tau=tau*0.9.

In the equation, tau is the value of tau from the previous exhalation cycle. In an alternative embodiment, the time constant may be adjusted based on the amount of undershoot detected, such as by a proportional amount based on the relative difference between the measured undershoot and the threshold. Other factors could also be used to determine the amount to adjust the undershoot including measured EEP, PEEP, and/or patient characteristics.


Based on the tau correction operation 608, the new tau value is then utilized to update the control command signal that is sent to the controller 110. This occurs in an operation 610. The updated tau value is inputted into the original control command equation, as discussed in relation to FIG. 3, shown below:

u(tk)=(uss−u0)*(1−exp(−tk/tau))+u0.

In the equation, the updated tau value is inputted into the control command equation which is sent to the controller 110. Based on this new control command, the opening of the exhalation valve is adjusted so that the expiratory flow undershoot falls within the appropriate threshold. Upon updating the control command, the method 600 terminates at the end operation 612.


Those skilled in the art will recognize that the methods and systems of the present disclosure may be implemented in many manners and as such are not to be limited by the foregoing exemplary embodiments and examples. In other words, functional elements being performed by a single or multiple components, in various combinations of hardware and software or firmware, and individual functions, can be distributed among software applications at either the client or server level or both. In this regard, any number of the features of the different embodiments described herein may be combined into single or multiple embodiments, and alternate embodiments having fewer than or more than all of the features herein described are possible. Functionality may also be, in whole or in part, distributed among multiple components, in manners now known or to become known. Thus, myriad software/hardware/firmware combinations are possible in achieving the functions, features, interfaces and preferences described herein. Moreover, the scope of the present disclosure covers conventionally known manners for carrying out the described features and functions and interfaces, and those variations and modifications that may be made to the hardware or software or firmware components described herein as would be understood by those skilled in the art now and hereafter.


Numerous other changes may be made which will readily suggest themselves to those skilled in the art and which are encompassed in the spirit of the disclosure and as defined in the appended claims. While various embodiments have been described for purposes of this disclosure, various changes and modifications may be made which are well within the scope of the present invention. Numerous other changes may be made which will readily suggest themselves to those skilled in the art and which are encompassed in the spirit of the disclosure and as defined in the appended claims.

Claims
  • 1. A method for controlling exhalation during ventilation of a patient on a ventilator, the method comprising: determining a control command for an exhalation valve, wherein the control command targets a pressure at the exhalation valve between a minimum pressure and a steady-state pressure for a period of time;controlling the exhalation valve based on the control command during one or more exhalation cycles;monitoring an end exhalation pressure and a flow undershoot during the one or more exhalation cycles;comparing the end exhalation pressure to a predetermined pressure range;comparing the flow undershoot to a predetermined flow threshold; andbased on the comparing, updating the control command in order to maintain a positive-end expiratory pressure (PEEP) at the end of the one or more exhalation cycles.
  • 2. The method of claim 1, wherein the pressure is lower than the PEEP.
  • 3. The method of claim 1 wherein the period of time is two breath cycles.
  • 4. The method of claim 1, wherein the control command is determined by an equation: u(tk)=(uss−u0)*(1−exp(−tk/tau))+u0,wherein tau=sum*(the predetermined number of breath cycles)/(uss−u0),wherein sum=sum+uss−u0,wherein tk is an exhalation time,wherein u0 is the minimum pressure during the period of time, andwherein uss is the steady-state pressure during the period of time.
  • 5. The method of claim 1 wherein comparing the end exhalation pressure to the predetermined pressure range further comprises: determining an average end exhalation pressure based on the end exhalation pressures of a prior number of exhalation cycles; anddetermining whether the average end exhalation pressure falls outside of the predetermined pressure range.
  • 6. The method of claim 5 wherein the prior number of exhalation cycles is 10.
  • 7. The method of claim 5 wherein determining whether the average end exhalation pressure falls outside of the predetermined pressure range further comprises: calculating a difference between the average end exhalation pressure and the PEEP; anddetermining whether the difference falls outside of the predetermined pressure range.
  • 8. The method of claim 1 wherein comparing the flow undershoot to the predetermined flow threshold further comprises: measuring an expiratory flow of the exhalation valve during the one or more exhalation cycles;determining the flow undershoot of the expiratory flow; anddetermining whether the flow undershoot falls under the predetermined flow threshold.
  • 9. The method of claim 1 wherein the predetermined flow threshold is 0.2 L/min.
  • 10. The method of claim 1 further comprising terminating control of the exhalation valve upon detection of an end condition.
  • 11. A ventilator system, comprising: means for determining a control command for an exhalation valve, wherein the control command targets a pressure at the exhalation valve between a minimum pressure and a steady-state pressure for a period of time;means for controlling the exhalation valve based on the control command during one or more exhalation cycles;means for monitoring an end exhalation pressure and a flow undershoot during the one or more exhalation cycles;means for comparing the end exhalation pressure to a predetermined pressure range;means for comparing the flow undershoot to a predetermined flow threshold; andbased on the comparing, means for updating the control command in order to maintain a positive-end expiratory pressure (PEEP) at the end of the one or more exhalation cycles.
  • 12. A computer-readable medium having computer-executable instructions for performing a method controlling exhalation during ventilation of a patient on a ventilator, the method comprising: determining a control command for an exhalation valve, wherein the control command targets a pressure at the exhalation valve between a minimum pressure and a steady-state pressure for a period of time;repeatedly controlling the exhalation valve based on the control command during one or more exhalation cycles;repeatedly monitoring an end exhalation pressure and a flow undershoot during the one or more exhalation cycles;repeatedly comparing the end exhalation pressure to a predetermined pressure range;repeatedly comparing the flow undershoot to a predetermined flow threshold; andbased on the comparing, repeatedly updating the control command in order to maintain a positive-end expiratory pressure (PEEP) at the end of the one or more exhalation cycles.
  • 13. The method of claim 12, wherein the pressure is lower than the PEEP.
  • 14. The method of claim 12 wherein repeatedly comparing the end exhalation pressure to the predetermined pressure range further comprises: repeatedly determining an average end exhalation pressure based on the end exhalation pressures of a prior number of exhalation cycles; andrepeatedly determining whether the average end exhalation pressure falls outside of the predetermined pressure range.
  • 15. The method of claim 14 wherein repeatedly determining whether the average end exhalation pressure falls outside of the predetermined pressure range further comprises: repeatedly calculating a difference between the average end exhalation pressure and the PEEP; andrepeatedly determining whether the difference falls outside of the predetermined pressure range.
  • 16. The method of claim 12 wherein repeatedly comparing the flow undershoot to the predetermined flow threshold further comprises: repeatedly measuring an expiratory flow of the exhalation valve during the one or more exhalation cycles;repeatedly determining the flow undershoot of the expiratory flow; andrepeatedly determining whether the flow undershoot falls under the predetermined flow threshold.
US Referenced Citations (566)
Number Name Date Kind
3444857 Godel May 1969 A
3481333 Garrison Dec 1969 A
3485243 Bird et al. Dec 1969 A
3688794 Bird et al. Sep 1972 A
4241756 Bennett et al. Dec 1980 A
4527557 DeVries et al. Jul 1985 A
4608976 Suchy Sep 1986 A
4699137 Schroeder Oct 1987 A
RE32553 Bennett et al. Dec 1987 E
4712580 Gilman et al. Dec 1987 A
4727871 Smargiassi et al. Mar 1988 A
4752089 Carter Jun 1988 A
4921642 LaTorraca May 1990 A
4954799 Kumar Sep 1990 A
4957107 Sipin Sep 1990 A
4991576 Henkin et al. Feb 1991 A
4993269 Guillaume et al. Feb 1991 A
5000173 Zalkin et al. Mar 1991 A
5020532 Mahoney et al. Jun 1991 A
5057822 Hoffman Oct 1991 A
5072729 DeVries Dec 1991 A
5072737 Goulding Dec 1991 A
5109838 Elam May 1992 A
5127400 DeVries et al. Jul 1992 A
5134995 Gruenke et al. Aug 1992 A
5150291 Cummings et al. Sep 1992 A
5161525 Kimm et al. Nov 1992 A
5168868 Hicks Dec 1992 A
5178155 Mault Jan 1993 A
5237987 Anderson et al. Aug 1993 A
5255675 Kolobow Oct 1993 A
5259373 Gruenke et al. Nov 1993 A
5269293 Loser et al. Dec 1993 A
5271389 Isaza et al. Dec 1993 A
5277175 Riggs et al. Jan 1994 A
5279549 Ranford Jan 1994 A
5299568 Forare et al. Apr 1994 A
5301667 McGrail et al. Apr 1994 A
5301921 Kumar Apr 1994 A
5303699 Bonassa et al. Apr 1994 A
5309901 Beaussant May 1994 A
5319540 Isaza et al. Jun 1994 A
5325861 Goulding Jul 1994 A
5331995 Westfall et al. Jul 1994 A
5333606 Schneider et al. Aug 1994 A
5339807 Carter Aug 1994 A
5343857 Schneider et al. Sep 1994 A
5343858 Winefordner et al. Sep 1994 A
5351522 Lura Oct 1994 A
5357946 Kee et al. Oct 1994 A
5368019 LaTorraca Nov 1994 A
5368021 Beard et al. Nov 1994 A
5383449 Forare et al. Jan 1995 A
5385142 Brady et al. Jan 1995 A
5390666 Kimm et al. Feb 1995 A
5398677 Smith Mar 1995 A
5401135 Stoen et al. Mar 1995 A
5402796 Packer et al. Apr 1995 A
5407174 Kumar Apr 1995 A
5413110 Cummings et al. May 1995 A
5438980 Phillips Aug 1995 A
5443075 Holscher Aug 1995 A
5452714 Anderson et al. Sep 1995 A
5467766 Ansite et al. Nov 1995 A
5484270 Adahan Jan 1996 A
5494028 DeVries et al. Feb 1996 A
5497767 Olsson et al. Mar 1996 A
5503140 Winefordner et al. Apr 1996 A
5513631 McWilliams May 1996 A
5517983 Deighan et al. May 1996 A
5520071 Jones May 1996 A
5524615 Power Jun 1996 A
5531221 Power Jul 1996 A
5540220 Gropper et al. Jul 1996 A
5542415 Brady Aug 1996 A
5542416 Chalvignac Aug 1996 A
5544674 Kelly Aug 1996 A
5546935 Champeau Aug 1996 A
5549106 Gruenke et al. Aug 1996 A
5568910 Koehler et al. Oct 1996 A
5572993 Kurome et al. Nov 1996 A
5575283 Sjoestrand Nov 1996 A
5596984 O'Mahoney et al. Jan 1997 A
5606968 Mang Mar 1997 A
5617847 Howe Apr 1997 A
5630411 Holscher May 1997 A
5632270 O'Mahony et al. May 1997 A
5645048 Brodsky et al. Jul 1997 A
5657750 Colman et al. Aug 1997 A
5660171 Kimm et al. Aug 1997 A
5662099 Tobia et al. Sep 1997 A
5664560 Merrick et al. Sep 1997 A
5664562 Bourdon Sep 1997 A
5671767 Kelly Sep 1997 A
5672041 Ringdahl et al. Sep 1997 A
5673689 Power Oct 1997 A
5678537 Bathe et al. Oct 1997 A
5683232 Adahan Nov 1997 A
5692497 Schnitzer et al. Dec 1997 A
5697363 Hart Dec 1997 A
5701883 Hete et al. Dec 1997 A
5701889 Danon Dec 1997 A
5715812 Deighan et al. Feb 1998 A
5762480 Adahan Jun 1998 A
5771884 Yarnall et al. Jun 1998 A
5791339 Winter Aug 1998 A
5794614 Gruenke et al. Aug 1998 A
5794986 Gansel et al. Aug 1998 A
5797393 Kohl Aug 1998 A
5803064 Phelps et al. Sep 1998 A
5813399 Isaza et al. Sep 1998 A
5823179 Grychowski et al. Oct 1998 A
5826575 Lall Oct 1998 A
5829441 Kidd et al. Nov 1998 A
5845636 Gruenke et al. Dec 1998 A
5857458 Tham et al. Jan 1999 A
5864938 Gansel et al. Feb 1999 A
5865168 Isaza Feb 1999 A
5868133 DeVries et al. Feb 1999 A
5875783 Kullik Mar 1999 A
5876352 Weismann Mar 1999 A
5881717 Isaza Mar 1999 A
5881722 DeVries et al. Mar 1999 A
5881723 Wallace et al. Mar 1999 A
5884623 Winter Mar 1999 A
5909731 O'Mahony et al. Jun 1999 A
5915379 Wallace et al. Jun 1999 A
5915380 Wallace et al. Jun 1999 A
5915382 Power Jun 1999 A
5918597 Jones et al. Jul 1999 A
5921238 Bourdon Jul 1999 A
5934274 Merrick et al. Aug 1999 A
5937856 Jonasson et al. Aug 1999 A
5941846 Duffy et al. Aug 1999 A
5957130 Krahbichler et al. Sep 1999 A
6024089 Wallace et al. Feb 2000 A
6041777 Faithfull et al. Mar 2000 A
6041780 Richard et al. Mar 2000 A
6047860 Sanders Apr 2000 A
6073630 Adahan Jun 2000 A
6076523 Jones et al. Jun 2000 A
6095139 Psaros Aug 2000 A
6102038 DeVries Aug 2000 A
6116240 Merrick et al. Sep 2000 A
6116464 Sanders Sep 2000 A
6119686 Somerson et al. Sep 2000 A
6123073 Schlawin et al. Sep 2000 A
6123074 Hete et al. Sep 2000 A
6131571 Lampotang et al. Oct 2000 A
6135106 Dirks et al. Oct 2000 A
6135967 Fiorenza et al. Oct 2000 A
6142150 O'Mahony Nov 2000 A
6148814 Clemmer et al. Nov 2000 A
6152132 Psaros Nov 2000 A
6152135 DeVries et al. Nov 2000 A
6158432 Biondi et al. Dec 2000 A
6161539 Winter Dec 2000 A
6176234 Salter et al. Jan 2001 B1
6192885 Jalde Feb 2001 B1
6217524 Orr et al. Apr 2001 B1
6220245 Takabayashi et al. Apr 2001 B1
6269812 Wallace et al. Aug 2001 B1
6273444 Power Aug 2001 B1
6283119 Bourdon Sep 2001 B1
6287264 Hoffman Sep 2001 B1
6295330 Skog et al. Sep 2001 B1
6295985 Kock et al. Oct 2001 B1
6305373 Wallace et al. Oct 2001 B1
6306098 Orr et al. Oct 2001 B1
6308706 Lammers et al. Oct 2001 B1
6309360 Mault Oct 2001 B1
6321748 O'Mahoney Nov 2001 B1
6325785 Babkes et al. Dec 2001 B1
6349922 Rydin Feb 2002 B1
6357438 Hansen Mar 2002 B1
6360745 Wallace et al. Mar 2002 B1
6369838 Wallace et al. Apr 2002 B1
6371113 Tobia et al. Apr 2002 B1
6412483 Jones et al. Jul 2002 B1
6415788 Clawson et al. Jul 2002 B1
6419634 Gaston, IV et al. Jul 2002 B1
6439229 Du et al. Aug 2002 B1
6457472 Schwartz et al. Oct 2002 B1
6467478 Merrick et al. Oct 2002 B1
6523537 Mas Marfany Feb 2003 B1
6523538 Wikefeldt Feb 2003 B1
6526970 DeVries et al. Mar 2003 B2
6543449 Woodring et al. Apr 2003 B1
6546930 Emerson et al. Apr 2003 B1
6550479 Duxbury Apr 2003 B1
6553991 Isaza Apr 2003 B1
6557553 Borrello May 2003 B1
6557554 Sugiura May 2003 B1
6564798 Jalde May 2003 B1
6571795 Bourdon Jun 2003 B2
6572561 Mault Jun 2003 B2
6575164 Jaffe et al. Jun 2003 B1
6575165 Cook et al. Jun 2003 B1
6575918 Kline Jun 2003 B2
6584973 Biondi et al. Jul 2003 B1
6606994 Clark Aug 2003 B1
6616615 Mault Sep 2003 B2
6619289 Mashak Sep 2003 B1
6622725 Fisher et al. Sep 2003 B1
6622726 Du Sep 2003 B1
6629934 Mault et al. Oct 2003 B2
6631716 Robinson et al. Oct 2003 B1
6644310 Delache et al. Nov 2003 B1
6668824 Isaza et al. Dec 2003 B1
6675801 Wallace et al. Jan 2004 B2
6718974 Moberg Apr 2004 B1
6722359 Chalvignac Apr 2004 B2
6723055 Hoffman Apr 2004 B2
6725447 Gilman et al. Apr 2004 B1
6729331 Kay May 2004 B2
6739334 Valeij May 2004 B2
6739337 Isaza May 2004 B2
6761167 Nadjafizadeh et al. Jul 2004 B1
6761168 Nadjafizadeh et al. Jul 2004 B1
6763829 Jaffe et al. Jul 2004 B2
6772762 Piesinger Aug 2004 B2
6805121 Flood et al. Oct 2004 B1
6814074 Nadjafizadeh et al. Nov 2004 B1
6866040 Bourdon Mar 2005 B1
6877511 DeVries et al. Apr 2005 B2
6886558 Tanaka May 2005 B2
6896713 Eckerbom et al. May 2005 B1
6938619 Hickle Sep 2005 B1
6960854 Nadjafizadeh et al. Nov 2005 B2
6968840 Smith et al. Nov 2005 B2
7032589 Kerechanin, II et al. Apr 2006 B2
7036504 Wallace et al. May 2006 B2
7040315 Strömberg May 2006 B1
7040321 Göbel May 2006 B2
7043979 Smith et al. May 2006 B2
7066175 Hamilton et al. Jun 2006 B2
7066177 Pittaway et al. Jun 2006 B2
7077131 Hansen Jul 2006 B2
RE39225 Isaza et al. Aug 2006 E
7117438 Wallace et al. Oct 2006 B2
7118537 Baddour Oct 2006 B2
7121277 Ström Oct 2006 B2
7152604 Hickle et al. Dec 2006 B2
7168597 Jones et al. Jan 2007 B1
7195013 Lurie Mar 2007 B2
7210478 Banner et al. May 2007 B2
7222623 DeVries et al. May 2007 B2
7241269 McCawley et al. Jul 2007 B2
7270126 Wallace et al. Sep 2007 B2
7275540 Bolam et al. Oct 2007 B2
7291115 Cardona Burrul Nov 2007 B2
7302949 Pelerossi et al. Dec 2007 B2
7320321 Pranger et al. Jan 2008 B2
7347825 Vaughan et al. Mar 2008 B2
7369757 Farbarik May 2008 B2
7370650 Nadjafizadeh et al. May 2008 B2
7392806 Yuen et al. Jul 2008 B2
7428902 Du et al. Sep 2008 B2
7460959 Jafari Dec 2008 B2
7475685 Dietz et al. Jan 2009 B2
7484508 Younes Feb 2009 B2
7487773 Li Feb 2009 B2
7487778 Freitag Feb 2009 B2
7500483 Colman et al. Mar 2009 B2
7509957 Duquette et al. Mar 2009 B2
7525663 Kwok et al. Apr 2009 B2
7533670 Freitag et al. May 2009 B1
7547285 Kline Jun 2009 B2
7556038 Kirby et al. Jul 2009 B2
7556042 West et al. Jul 2009 B2
7562657 Blanch et al. Jul 2009 B2
7588033 Wondka Sep 2009 B2
7610914 Bolam et al. Nov 2009 B2
7617824 Doyle Nov 2009 B2
7621271 Brugnoli Nov 2009 B2
7634998 Fenley Dec 2009 B1
7654802 Crawford, Jr. et al. Feb 2010 B2
7694677 Tang Apr 2010 B2
7699788 Kuck et al. Apr 2010 B2
7717113 Andrieux May 2010 B2
7721735 Hamilton et al. May 2010 B2
7721736 Urias et al. May 2010 B2
D618356 Ross Jun 2010 S
7740591 Starr et al. Jun 2010 B1
7753052 Tanaka Jul 2010 B2
7779840 Acker et al. Aug 2010 B2
7784461 Figueiredo et al. Aug 2010 B2
7810497 Pittman et al. Oct 2010 B2
7814908 Psaros Oct 2010 B2
7819815 Younes Oct 2010 B2
7823588 Hansen Nov 2010 B2
7828741 Kline et al. Nov 2010 B2
7846739 von Bahr et al. Dec 2010 B2
7849854 DeVries et al. Dec 2010 B2
7855716 McCreary et al. Dec 2010 B2
7861716 Borrello Jan 2011 B2
7870857 Dhuper et al. Jan 2011 B2
D632796 Ross et al. Feb 2011 S
D632797 Ross et al. Feb 2011 S
7883471 Aljuri et al. Feb 2011 B2
7885771 Roecker et al. Feb 2011 B2
7891354 Farbarik Feb 2011 B2
7893560 Carter Feb 2011 B2
7900626 Daly Mar 2011 B2
7913690 Fisher et al. Mar 2011 B2
D638852 Skidmore et al. May 2011 S
7984714 Hausmann et al. Jul 2011 B2
D643535 Ross et al. Aug 2011 S
7992557 Nadjafizadeh et al. Aug 2011 B2
8001967 Wallace et al. Aug 2011 B2
D645158 Sanchez et al. Sep 2011 S
8021310 Sanborn et al. Sep 2011 B2
D649157 Skidmore et al. Nov 2011 S
D652521 Ross et al. Jan 2012 S
D652936 Ross et al. Jan 2012 S
D653749 Winter et al. Feb 2012 S
8113062 Graboi et al. Feb 2012 B2
D655405 Winter et al. Mar 2012 S
D655809 Winter et al. Mar 2012 S
D656237 Sanchez et al. Mar 2012 S
8181648 Perine et al. May 2012 B2
8210173 Vandine Jul 2012 B2
8210174 Farbarik Jul 2012 B2
8240684 Ross et al. Aug 2012 B2
8267085 Jafari et al. Sep 2012 B2
8272379 Jafari et al. Sep 2012 B2
8272380 Jafari et al. Sep 2012 B2
8302600 Andrieux et al. Nov 2012 B2
8302602 Andrieux et al. Nov 2012 B2
20020026941 Biondi et al. Mar 2002 A1
20020138213 Mault Sep 2002 A1
20030062045 Woodring et al. Apr 2003 A1
20040138577 Kline Jul 2004 A1
20040261793 Stromberg et al. Dec 2004 A1
20050039748 Andrieux Feb 2005 A1
20050098177 Haj-Yahya et al. May 2005 A1
20050139211 Alston et al. Jun 2005 A1
20050139212 Bourdon Jun 2005 A1
20050150494 DeVries et al. Jul 2005 A1
20050217671 Fisher et al. Oct 2005 A1
20060032499 Halsnes Feb 2006 A1
20060129054 Orr et al. Jun 2006 A1
20060130839 Bassovitch Jun 2006 A1
20060201507 Breen Sep 2006 A1
20060249148 Younes Nov 2006 A1
20060249153 DeVries et al. Nov 2006 A1
20070000494 Banner et al. Jan 2007 A1
20070017515 Wallace et al. Jan 2007 A1
20070028921 Banner et al. Feb 2007 A1
20070062531 Fisher et al. Mar 2007 A1
20070068530 Pacey Mar 2007 A1
20070073183 Kline Mar 2007 A1
20070077200 Baker Apr 2007 A1
20070095347 Lampotang et al. May 2007 A1
20070113854 Mcauliffe May 2007 A1
20070125377 Heinonen et al. Jun 2007 A1
20070144521 DeVries et al. Jun 2007 A1
20070144523 Bolam et al. Jun 2007 A1
20070157930 Soliman et al. Jul 2007 A1
20070157931 Parker et al. Jul 2007 A1
20070163579 Li et al. Jul 2007 A1
20070227537 Bemister et al. Oct 2007 A1
20070232952 Baddour Oct 2007 A1
20070255160 Daly Nov 2007 A1
20070284361 Nadjafizadeh et al. Dec 2007 A1
20080045825 Melker et al. Feb 2008 A1
20080053438 DeVries et al. Mar 2008 A1
20080053441 Gottlib et al. Mar 2008 A1
20080060646 Isaza Mar 2008 A1
20080060656 Isaza Mar 2008 A1
20080072896 Setzer et al. Mar 2008 A1
20080072902 Setzer et al. Mar 2008 A1
20080078390 Milne et al. Apr 2008 A1
20080083644 Janbakhsh et al. Apr 2008 A1
20080092894 Nicolazzi et al. Apr 2008 A1
20080097234 Nicolazzi et al. Apr 2008 A1
20080135044 Freitag et al. Jun 2008 A1
20080183094 Schonfuss et al. Jul 2008 A1
20080196720 Kollmeyer et al. Aug 2008 A1
20080202517 Mitton et al. Aug 2008 A1
20080202518 Mitton et al. Aug 2008 A1
20080214947 Hunt et al. Sep 2008 A1
20080230062 Tham Sep 2008 A1
20080257349 Hedner et al. Oct 2008 A1
20080276939 Tiedje Nov 2008 A1
20090000621 Haggblom et al. Jan 2009 A1
20090007914 Bateman Jan 2009 A1
20090050153 Brunner Feb 2009 A1
20090056708 Stenzler et al. Mar 2009 A1
20090056719 Newman, Jr. Mar 2009 A1
20090071478 Kalfon Mar 2009 A1
20090078251 Zucchi et al. Mar 2009 A1
20090084381 DeVries et al. Apr 2009 A1
20090090359 Daviet et al. Apr 2009 A1
20090114223 Bonassa May 2009 A1
20090133695 Rao et al. May 2009 A1
20090137919 Bar-Lavie et al. May 2009 A1
20090165795 Nadjafizadeh et al. Jul 2009 A1
20090171176 Andersohn Jul 2009 A1
20090188502 Tiedje Jul 2009 A1
20090205661 Stephenson et al. Aug 2009 A1
20090205663 Vandine et al. Aug 2009 A1
20090217923 Boehm et al. Sep 2009 A1
20090221926 Younes Sep 2009 A1
20090229612 Levi et al. Sep 2009 A1
20090235935 Pacey Sep 2009 A1
20090241948 Clancy et al. Oct 2009 A1
20090241951 Jafari et al. Oct 2009 A1
20090241952 Nicolazzi et al. Oct 2009 A1
20090241953 Vandine et al. Oct 2009 A1
20090241955 Jafari et al. Oct 2009 A1
20090241956 Baker, Jr. et al. Oct 2009 A1
20090241957 Baker, Jr. Oct 2009 A1
20090241958 Baker, Jr. Oct 2009 A1
20090241962 Jafari et al. Oct 2009 A1
20090241964 Aljuri et al. Oct 2009 A1
20090247891 Wood Oct 2009 A1
20090250054 Loncar et al. Oct 2009 A1
20090250059 Allum et al. Oct 2009 A1
20090255533 Freitag et al. Oct 2009 A1
20090260625 Wondka Oct 2009 A1
20090263279 Kline et al. Oct 2009 A1
20090270752 Coifman Oct 2009 A1
20090277448 Ahlmén et al. Nov 2009 A1
20090293877 Blanch et al. Dec 2009 A1
20090299430 Davies et al. Dec 2009 A1
20090301486 Masic Dec 2009 A1
20090301487 Masic Dec 2009 A1
20090301490 Masic Dec 2009 A1
20090301491 Masic et al. Dec 2009 A1
20100011307 Desfossez et al. Jan 2010 A1
20100012126 Gandini Jan 2010 A1
20100024820 Bourdon Feb 2010 A1
20100031961 Schmidt Feb 2010 A1
20100051026 Graboi Mar 2010 A1
20100051029 Jafari et al. Mar 2010 A1
20100059058 Kuo Mar 2010 A1
20100069761 Karst et al. Mar 2010 A1
20100071689 Thiessen Mar 2010 A1
20100071692 Porges Mar 2010 A1
20100071695 Thiessen Mar 2010 A1
20100071696 Jafari Mar 2010 A1
20100071697 Jafari et al. Mar 2010 A1
20100078017 Andrieux et al. Apr 2010 A1
20100078026 Andrieux et al. Apr 2010 A1
20100081119 Jafari et al. Apr 2010 A1
20100081955 Wood, Jr. et al. Apr 2010 A1
20100099999 Hemnes et al. Apr 2010 A1
20100101577 Kaestle et al. Apr 2010 A1
20100106037 Kacmarek et al. Apr 2010 A1
20100125227 Bird May 2010 A1
20100137733 Wang et al. Jun 2010 A1
20100139660 Adahan Jun 2010 A1
20100147302 Selvarajan et al. Jun 2010 A1
20100147303 Jafari et al. Jun 2010 A1
20100170512 Kuypers et al. Jul 2010 A1
20100175695 Jamison Jul 2010 A1
20100179392 Chang et al. Jul 2010 A1
20100180897 Malgouyres Jul 2010 A1
20100185112 Van Kesteren et al. Jul 2010 A1
20100186744 Andrieux Jul 2010 A1
20100198095 Isler Aug 2010 A1
20100218765 Jafari et al. Sep 2010 A1
20100218766 Milne Sep 2010 A1
20100218767 Jafari et al. Sep 2010 A1
20100222692 McCawley et al. Sep 2010 A1
20100236553 Jafari et al. Sep 2010 A1
20100236555 Jafari et al. Sep 2010 A1
20100241019 Varga et al. Sep 2010 A1
20100242961 Mougel et al. Sep 2010 A1
20100249584 Albertelli Sep 2010 A1
20100252042 Kapust et al. Oct 2010 A1
20100268106 Johnson et al. Oct 2010 A1
20100268131 Efthimiou Oct 2010 A1
20100269834 Freitag et al. Oct 2010 A1
20100282258 Tailor et al. Nov 2010 A1
20100282259 Figueiredo et al. Nov 2010 A1
20100286544 Tanaka et al. Nov 2010 A1
20100288283 Campbell et al. Nov 2010 A1
20100292601 Dompeling et al. Nov 2010 A1
20100300446 Nicolazzi et al. Dec 2010 A1
20100324437 Freeman et al. Dec 2010 A1
20100324439 Davenport Dec 2010 A1
20110004108 Peyton Jan 2011 A1
20110009762 Eichler et al. Jan 2011 A1
20110011400 Gentner et al. Jan 2011 A1
20110023878 Thiessen Feb 2011 A1
20110023879 Vandine et al. Feb 2011 A1
20110023880 Thiessen Feb 2011 A1
20110023881 Thiessen Feb 2011 A1
20110029910 Thiessen Feb 2011 A1
20110041849 Chen et al. Feb 2011 A1
20110041850 Vandine et al. Feb 2011 A1
20110066060 von Bahr et al. Mar 2011 A1
20110126829 Carter et al. Jun 2011 A1
20110126832 Winter et al. Jun 2011 A1
20110126834 Winter et al. Jun 2011 A1
20110126835 Winter et al. Jun 2011 A1
20110126836 Winter et al. Jun 2011 A1
20110126837 Winter et al. Jun 2011 A1
20110128008 Carter Jun 2011 A1
20110132361 Sanchez Jun 2011 A1
20110132362 Sanchez Jun 2011 A1
20110132364 Ogilvie et al. Jun 2011 A1
20110132365 Patel et al. Jun 2011 A1
20110132366 Ogilvie et al. Jun 2011 A1
20110132367 Patel Jun 2011 A1
20110132368 Sanchez et al. Jun 2011 A1
20110132369 Sanchez Jun 2011 A1
20110132371 Sanchez et al. Jun 2011 A1
20110133936 Sanchez et al. Jun 2011 A1
20110138308 Palmer et al. Jun 2011 A1
20110138309 Skidmore et al. Jun 2011 A1
20110138311 Palmer Jun 2011 A1
20110138315 Vandine et al. Jun 2011 A1
20110138323 Skidmore et al. Jun 2011 A1
20110146681 Jafari et al. Jun 2011 A1
20110146683 Jafari et al. Jun 2011 A1
20110154241 Skidmore et al. Jun 2011 A1
20110175728 Baker, Jr. Jul 2011 A1
20110196251 Jourdain et al. Aug 2011 A1
20110209702 Vuong et al. Sep 2011 A1
20110209704 Jafari et al. Sep 2011 A1
20110209707 Terhark Sep 2011 A1
20110213215 Doyle et al. Sep 2011 A1
20110230780 Sanborn et al. Sep 2011 A1
20110249006 Wallace et al. Oct 2011 A1
20110259330 Jafari et al. Oct 2011 A1
20110259332 Sanchez et al. Oct 2011 A1
20110259333 Sanchez et al. Oct 2011 A1
20110265024 Leone et al. Oct 2011 A1
20110271960 Milne et al. Nov 2011 A1
20110273299 Milne et al. Nov 2011 A1
20120000467 Milne et al. Jan 2012 A1
20120000468 Milne et al. Jan 2012 A1
20120000469 Milne et al. Jan 2012 A1
20120000470 Milne et al. Jan 2012 A1
20120029317 Doyle et al. Feb 2012 A1
20120030611 Skidmore Feb 2012 A1
20120060841 Crawford, Jr. et al. Mar 2012 A1
20120071729 Doyle et al. Mar 2012 A1
20120090611 Graboi et al. Apr 2012 A1
20120096381 Milne et al. Apr 2012 A1
20120133519 Milne et al. May 2012 A1
20120136222 Doyle et al. May 2012 A1
20120137249 Milne et al. May 2012 A1
20120137250 Milne et al. May 2012 A1
20120167885 Masic et al. Jul 2012 A1
20120185792 Kimm et al. Jul 2012 A1
20120197578 Vig et al. Aug 2012 A1
20120197580 Vij et al. Aug 2012 A1
20120211008 Perine et al. Aug 2012 A1
20120216809 Milne et al. Aug 2012 A1
20120216810 Jafari et al. Aug 2012 A1
20120216811 Kimm et al. Aug 2012 A1
20120226444 Milne et al. Sep 2012 A1
20120247471 Masic et al. Oct 2012 A1
20120272960 Milne Nov 2012 A1
20120272961 Masic et al. Nov 2012 A1
20120272962 Doyle et al. Nov 2012 A1
20120304995 Kauc Dec 2012 A1
20130000644 Thiessen Jan 2013 A1
20130006133 Doyle et al. Jan 2013 A1
20130006134 Doyle et al. Jan 2013 A1
20130025596 Jafari et al. Jan 2013 A1
20130025597 Doyle et al. Jan 2013 A1
Foreign Referenced Citations (1)
Number Date Country
WO 2007102866 Sep 2007 WO
Non-Patent Literature Citations (5)
Entry
7200 Series Ventilator, Options, and Accessories: Operator's Manual. Nellcor Puritan Bennett, Part No. 22300 A, Sep. 1990, pp. 1-196.
7200 Ventilatory System: Addendum/Errata. Nellcor Puritan Bennett, Part No. 4-023576-00, Rev. A, Apr. 1988, pp. 1-32.
800 Operator's and Technical Reference Manual. Series Ventilator System, Nellcor Puritan Bennett, Part No. 4-070088-00, Rev. L, Aug. 2010, pp. 1-476.
840 Operator's and Technical Reference Manual. Ventilator System, Nellcor Puritan Bennett, Part No. 4-075609-00, Rev. G, Oct. 2006, pp. 1-424.
DeBlasi, Robert et al., “The Impact of Imposed Expiratory Resistance in Neonatal Mechanical Ventilation: A Laboratory Evaluation”, Respiratory Care, Nov. 2008, vol. 53, No. 11, pp. 1450-1460.
Related Publications (1)
Number Date Country
20130284177 A1 Oct 2013 US